Filing Flows › Arrowhead Pharmaceuticals (ARWR) › Free cash flow
Arrowhead Pharmaceuticals (ARWR) free cash flow by quarter
Arrowhead Pharmaceuticals' free cash flow was $81.9M in Q2 FY26 (second quarter fiscal 2026), +622% from Q1 FY26. Over the last 4 quarters it ranged from $11.3M (Q1 FY26) to $455M (Q2 FY25).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY26 | $81.9M | +622% | -82% |
| Q1 FY26 | $11.3M | -13% | — |
| Q4 FY25 | $13.0M | -97% | — |
| Q2 FY25 | $455M | — | — |
Q2 FY26 at a glance
Arrowhead Pharmaceuticals, Q2 FY26: revenue $73.7M (-86% year over year), operating margin -191.6%, net loss $138M, operating cash flow $84.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Arrowhead Pharmaceuticals' free cash flow?
Arrowhead Pharmaceuticals' free cash flow was $81.9M in Q2 FY26 (second quarter fiscal 2026), +622% from Q1 FY26.
How has Arrowhead Pharmaceuticals' free cash flow changed?
Over the last 4 quarters it ranged from $11.3M (Q1 FY26) to $455M (Q2 FY25).
Q2 FY26 results → · How Arrowhead Pharmaceuticals makes money →